Here are the 8-K filings from Scientific Industries Inc (SCND) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An 8-K covers material events a company has to report between its quarterly reports, so if you follow SCND and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SCND filings page.
Scientific Industries, Inc. entered into an employment agreement with Chief Financial Officer Zachary Rovinsky and extended employment agreements for President, Chief Executive Officer and Treasurer Helena Santos and Chairman of the Board John A. Moore. Rovinsky’s employment runs through September 30, 2028, with two additional one-year extensions possible by mutual consent. His annual salary is $210,000, with a bonus up to 10% of salary and annual salary increases of 3.0%.
Santos’s agreement runs through September 30, 2027, with a $200,000 base salary during that period; part may be paid in equity upon mutual agreement. Moore’s agreement is with Scientific Bioprocessing, Inc., Scientific Industries’ wholly owned subsidiary, and runs through September 30, 2027, with a $165,000 salary; part may also be paid in equity upon mutual agreement.
Scientific Industries, Inc. reported a change in its independent auditor following an acquisition within the accounting industry. Effective January 14, 2026, the company’s Audit Committee dismissed Berkowitz Pollack Brant Advisors + CPAs, LLP (BPB) and approved Carr, Riggs & Ingram, LLC (CRI) as the new independent registered public accounting firm, after CRI acquired certain assets related to BPB’s capital markets practice on January 1, 2026.
BPB had been engaged from August 22, 2025 through December 31, 2025 but issued no audit or review reports during that period. The company states there were no disagreements with BPB on accounting principles, financial statement disclosure, or auditing scope or procedures, and no reportable events under Regulation S‑K during the engagement. The company also states it did not consult with CRI on accounting or auditing matters before the appointment. BPB’s confirming letter to the SEC is filed as an exhibit.
Scientific Industries, Inc. has amended a prior current report to add pro forma financial information related to the sale of substantially all assets of its Genie Division of benchtop laboratory equipment to Troemner, LLC. Under the Asset Purchase Agreement dated August 7, 2025, the Genie line’s products, fixed assets, inventory, and intellectual property were transferred.
The purchase price is $9,600,000, subject to working capital adjustments, plus an earn-out of up to $1,500,000, including $1,140,000 tied to the company providing supply and transition services such as product supply, training, and know-how transfer for at least six months and up to twelve months. Scientific Industries will continue to operate its Torbal Division of benchtop laboratory equipment from Bohemia, New York, and has filed unaudited pro forma balance sheet and income statement information as Exhibit 99.1.